Medicine research news Return to previous page
Article Released Mon-15th-May-2017 04:15 GMT
Contact: Katrina-Kay Sepulveda Alaimo Institution: Hokkaido University
 Natural defense mechanism preventing cancer at the earliest stage

A new study shows cells in the initial stage of cancer change their metabolism before getting eliminated by the surrounding normal cells, providing a novel target for developing cancer prevention drugs.

Transformed cells
Transformed cells (RasV12, green) showed reduced mitochondrial membrane potential (TMRM, red) when surrounded by normal epithelial cells.
Copyright : (Kon S., et al., Nature Cell Biology, April 17, 2017)
Most cancers begin when one or more genes in a cell mutate. These newly “transformed” cells get extruded and eliminated after losing a competition against the surrounding normal cells in the epithelium, or the outer layer of the body. However, the mechanism by which normal cells recognize and attack the transformed cells remains elusive.

A research team led by Professor Yasuyuki Fujita of Hokkaido University’s Institute for Genetic Medicine explored this natural defense mechanism using cultured mammalian cells and a mouse model. The study uncovered two metabolic changes occurring in the newly transformed cells: mitochondrial dysfunction and an elevated glucose uptake. The changes were significant only when the transformed cells were surrounded by normal epithelial cells, indicating that the changes are induced by the normal cells. Furthermore, according to the study, the metabolic changes play an important role in eliminating the transformed cells.

Interestingly, these metabolic changes are similar to the Warburg effect, which is observed in cancerous cells in the middle and latter stages of cancer. The Warburg effect is generally thought to play tumor promoting roles whereas the newly discovered metabolic changes could suppress cancer in its initial stage. “Although these two processes have similar metabolic alterations, mitochondrial downregulation and increased glycolysis, they are governed by distinct regulators and have opposing effects on the development of cancer,” says Fujita.

Their findings shed new light on the inherent ability of normal cells to eliminate cancerous cells and opens up potential avenues for cancer prevention. “Considering that the metabolic changes could either suppress or promote cancer cells depending on the stage, further elucidation of the mechanism is essential to help develop cancer prevention drugs while avoiding adverse effects,” Fujita commented.

This research was conducted by scientists from Hokkaido University, Kyoto University, Kanazawa University, Keio University, Osaka University and University College London, and published in the May issue of Nature Cell Biology. The paper is also featured in the “News and Views” section of the issue.

Associated links

Associated files available for download

Download IconView/download the file 'Fig1-Fujita_Movie1.mov.

Journal information

Nature Cell Biology

Funding information

Japan Society for the Promotion of Science, the AMED Strategic Japanese–Swiss Cooperative Program, Takeda Science Foundation, the Kato Memorial Bioscience Foundation and the YASUDA Medical Foundation.

Keywords associated to this article: cancer, RasV12, TMRM
Create Account...